“President Barack Obama [on Monday] proposed a $3.8 trillion budget for fiscal 2013 that aims to slash the deficit by $4 trillion over 10 years,” the Associated Press reports, and provides an agency-by-agency breakdown of the proposed budget (2/13). “Making up just one percent of the U.S. Government’s overall budget, the Department of State/USAID budget totals $51.6 billion,” a U.S. Department of State fact sheet notes (2/13). “Overall, funding for the Global Health Initiative (GHI) is down in the FY 2013 request, with most of the reduction coming from HIV/AIDS bilateral amounts,” according to the Kaiser Family Foundation’s Policy Tracker. “Most other areas saw decreases as well, except for family planning and funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, which increased,” the resource adds. The budget plan proposes a total of approximately $8.5 billion for GHI, down more than $300 million from FY 2012, the resource notes, adding that $6.4 billion of that funding would go to PEPFAR, including about $4.5 billion for HIV and $224 million for tuberculosis. The Global Fund receives $1.65 billion in the request, according to the resource (2/13).
“India is lagging in its effort to reach United Nations goals to reduce poverty and improve health and sanitation, but has shown significant progress boosting education, treating AIDS and addressing environmental concerns,” Noeleen Heyzer, executive secretary of the U.N. Economic and Social Commission for Asia and the Pacific, said last week, the New York Times’ “India Ink” blog reports. According to an Asia Pacific Millennium Development Goal (MDG) report (.pdf) released last week, which “graded the progress of the eight millennium goals using 22 socio-economic indicators …, India has reached goals set in seven indicators out of 22 and is on track to achieve three others, but is lagging behind in 12,” the blog notes.
In “the first in a series of conversations with officials at the Centers for Disease Control and Prevention (CDC) discussing the CDC’s role in global HIV and tuberculosis (TB) research and development,” the Center for Global Health Policy’s “Science Speaks” blog interviews Kayla Laserson, director of the Kenya Medical Research Institute (KEMRI)/CDC Field Research Station in Kisumu, Kenya. Laserson answers questions about her work with the CDC, the latest research projects underway at KEMRI/CDC, and progress in Kenya’s HIV response since she began working in Kisumu six years ago, among other topics (Mazzotta, 2/14).
In this New York Times opinion piece, Paul Farmer, chair of the department of global health and social medicine at Harvard Medical School and a co-founder of Partners in Health, examines the importance of the Global Fund to Fight AIDS, Tuberculosis and Malaria as it faces a “serious financial shortfall,” writing, “Beyond AIDS, the Global Fund is currently the largest donor in the world for tuberculosis and malaria programs. … The question is not whether the Global Fund works, but how to ensure it keeps working for years to come.”
The Guardian examines the future of the Global Fund to Fight AIDS, Tuberculosis and Malaria as it enters its second decade, writing, “Despite its staggering successes — including helping put 3.3 million people on AIDS treatment, 8.6 million on anti-tuberculosis treatment and providing 230 million insecticide-treated nets for the prevention of malaria — the fund’s recent troubles had threatened to overshadow its accomplishments as it prepared to mark a decade as the world’s main financier of programs to fight these three global epidemics.” The news service highlights a $750 million pledge to the Fund by Bill Gates, co-chair of the Bill & Melinda Gates Foundation, discusses recent managerial changes within the Fund, and quotes a number of experts about future challenges (Kelly, 2/2).
IRIN examines “whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of [tuberculosis (TB)] in developing countries.” The news service writes, “TB is a disease often associated with poverty because latent infections are more easily activated by malnutrition and lowered immune systems, and more quickly passed on in badly ventilated, overcrowded living conditions.”
Approximately 85,000 HIV-positive people in Burma, also known as Myanmar, are in need of antiretroviral treatment (ART) and cannot access it “due to a lack of funding, despite renewed international engagement with the government amid a wave of political reform, according to a report released Wednesday” by the medical aid group Medecins Sans Frontieres (MSF), the Associated Press/CBS News reports (2/22). “At the launch of a new report called ‘Lives in the Balance,’ MSF said that only a quarter of the estimated 120,000 people living with HIV and AIDS were receiving treatment, and that it was turning people away from its clinics,” BBC News writes. While plans were made last year among MSF and its partners to scale up treatment for HIV and tuberculosis (TB), “those proposals were shelved after the Global Fund” to Fight AIDS, Tuberculosis and Malaria cancelled its Round 11 grants, according to the news agency. “The money was expected to provide HIV drugs for 46,500 people in Myanmar, along with treatment for another 10,000 people sicken[ed] by drug-resistant tuberculosis in the country, [the report] said,” BBC writes (Fisher, 2/22).
CBS News examines the fight against tuberculosis (TB) in South Korea, which “has the highest incidence rate of tuberculosis among the world’s wealthiest countries, nations [that] belong to the 34-member Organization for Economic Cooperation and Development (OECD).” The news service continues, “In 2010, South Korea’s incidence rate of tuberculosis was 97 out of 100,000, according to the World Health Organization (WHO), while the mortality rate of TB was 5.4 out of 100,000. (In the U.S., the incidence rate was 4.1 and the mortality rate was 0.18 during the same time period.)”
“The Global Fund’s drive to ensure sustainability and efficiency means that it may not be able to meet its commitments to combat disease, says Laurie Garrett,” a senior fellow for global health at the Council on Foreign Relations, in Nature’s “World View” column. Citing his resignation letter, Garrett discusses the “the political struggle” that led Michel Kazatchkine to step down as executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria last week and writes, “It is a classic battle of titans, pitting urgency against long-term sustainability. … Kazatchkine essentially conceded victory to the forces for sustainability.”
“A pilot community program to improve [tuberculosis (TB)] detection in northern Tanzania has shown good results and could be replicated nationwide as the country seeks to improve its TB treatment and prevention systems,” IRIN reports. The program, run by Management Sciences for Health with help from PATH and Tanzania’s National Tuberculosis and Leprosy Programme and financial support from USAID, “emphasized that TB and HIV treatment must be done ‘hand in hand,'” according to IRIN.